These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 29556602)

  • 1. Tau protein in neurodegenerative diseases - a review.
    Pîrşcoveanu DFV; Pirici I; Tudorică V; Bălşeanu TA; Albu VC; Bondari S; Bumbea AM; Pîrşcoveanu M
    Rom J Morphol Embryol; 2017; 58(4):1141-1150. PubMed ID: 29556602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach.
    Iqbal K; Alonso AD; Gondal JA; Gong CX; Haque N; Khatoon S; Sengupta A; Wang JZ; Grundke-Iqbal I
    J Neural Transm Suppl; 2000; 59():213-22. PubMed ID: 10961432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau gene mutations and their effects.
    Goedert M
    Mov Disord; 2005 Aug; 20 Suppl 12():S45-52. PubMed ID: 16092090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The genetics of dementias. Part 1: Molecular basis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)].
    Kowalska A
    Postepy Hig Med Dosw (Online); 2009 Jun; 63():278-86. PubMed ID: 19535823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations causing neurodegenerative tauopathies.
    Goedert M; Jakes R
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):240-50. PubMed ID: 15615642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau gene mutations and neurodegeneration.
    Goedert M; Spillantini MG
    Biochem Soc Symp; 2001; (67):59-71. PubMed ID: 11447840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microtubule-associated protein tau gene: a risk factor in human neurodegenerative diseases.
    Schraen-Maschke S; Dhaenens CM; Delacourte A; Sablonnière B
    Neurobiol Dis; 2004 Apr; 15(3):449-60. PubMed ID: 15056452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into genetic and molecular mechanisms of brain degeneration in tauopathies.
    Forman MS; Lee VM; Trojanowski JQ
    J Chem Neuroanat; 2000 Dec; 20(3-4):225-44. PubMed ID: 11207421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal tau-containing filaments in neurodegenerative diseases.
    Crowther RA; Goedert M
    J Struct Biol; 2000 Jun; 130(2-3):271-9. PubMed ID: 10940231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau-based treatment strategies in neurodegenerative diseases.
    Schneider A; Mandelkow E
    Neurotherapeutics; 2008 Jul; 5(3):443-57. PubMed ID: 18625456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Going new places using an old MAP: tau, microtubules and human neurodegenerative disease.
    Garcia ML; Cleveland DW
    Curr Opin Cell Biol; 2001 Feb; 13(1):41-8. PubMed ID: 11163132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
    Goedert M
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau gene mutations: dissecting the pathogenesis of FTDP-17.
    Ingram EM; Spillantini MG
    Trends Mol Med; 2002 Dec; 8(12):555-62. PubMed ID: 12470988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of Tau and α-Synuclein Pathology in the Visual System.
    Rahimi J; Milenkovic I; Kovacs GG
    J Parkinsons Dis; 2015; 5(2):333-40. PubMed ID: 25737267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief update on different roles of tau in neurodegeneration.
    Ittner A; Ke YD; van Eersel J; Gladbach A; Götz J; Ittner LM
    IUBMB Life; 2011 Jul; 63(7):495-502. PubMed ID: 21698753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic zebrafish model of neurodegeneration.
    Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG
    J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H1 haplotype of the MAPT gene is associated with lower regional gray matter volume in healthy carriers.
    Canu E; Boccardi M; Ghidoni R; Benussi L; Testa C; Pievani M; Bonetti M; Binetti G; Frisoni GB
    Eur J Hum Genet; 2009 Mar; 17(3):287-94. PubMed ID: 18854867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argyrophilic grain disease.
    Ferrer I; Santpere G; van Leeuwen FW
    Brain; 2008 Jun; 131(Pt 6):1416-32. PubMed ID: 18234698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neuropathological spectrum of neurodegenerative tauopathies.
    Tolnay M; Probst A
    IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases.
    Goedert M; Spillantini MG; Serpell LC; Berriman J; Smith MJ; Jakes R; Crowther RA
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):213-27. PubMed ID: 11260802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.